- Home
- CGBD vs KURA Comparison
CGBD vs KURA Comparison
Compare CGBD & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | KURA |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | 2500 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 759.8M | 744.0M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CGBD | KURA |
|---|---|---|
| Price | $10.97 | $8.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $12.92 | ★ $25.88 |
| AVG Volume (30 Days) | 706.1K | ★ 1.3M |
| Earning Date | 05-05-2026 | 03-05-2026 |
| Dividend Yield | ★ 14.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | $3.74 | $62.31 |
| Revenue Next Year | $1.14 | $58.09 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $10.64 | $5.41 |
| 52 Week High | $16.36 | $12.49 |
Technical Indicators
Market Signals| Indicator | CGBD | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 45.45 |
| Support Level | $10.64 | $7.99 |
| Resistance Level | $13.06 | $10.50 |
| Average True Range (ATR) | 0.31 | 0.37 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 37.18 | 36.92 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.